Busan, South Korea

Jin-Sook Jeong

This inventor holds 4 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: National Cancer Center, Pohang University of Science and Technology Foundation, Posco. Active years: 2013-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jin-Sook Jeong. Retrieved from https://idiyas.com/inventor/jin-sook-jeong

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 50.0

 

Average Co-Inventor Count = 4.7

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2013-2018

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Jin-Sook Jeong

Introduction

Jin-Sook Jeong is a prominent inventor based in Busan, South Korea. She has made significant contributions to the field of cancer research through her innovative inventions. With a total of 4 patents, her work focuses on developing advanced therapeutic methods for cancer treatment.

Latest Patents

One of her latest patents is titled "Recombinant adenovirus with increased safety and anticancer activities, and use thereof." This invention relates to a recombinant adenovirus that demonstrates enhanced in-vivo safety, tissue specificity, and anticancer activities. The recombinant adenovirus includes a promoter of the liver tissue-specific phosphoenolpyruvate carboxykinase (PEPCK) gene, a trans-splicing ribozyme linked to the promoter, and a therapeutic or reporter gene. This innovative approach shows remarkable in-vivo safety and high specificity for target tissues, making it a potential candidate for anticancer drugs or cancer diagnostic agents.

Another significant patent is the "RNA aptamer specifically binding to carcinoembryonic antigen and use thereof." This invention provides an RNA aptamer that specifically binds to the cancer metastasis-inducing domain of carcinoembryonic antigen (CEA). It includes a composition for the prevention, inhibition, and diagnosis of cancer metastasis, showcasing a novel method for addressing cancer progression.

Career Highlights

Jin-Sook Jeong has worked with esteemed organizations such as the National Cancer Center and the Pohang University of Science and Technology Foundation. Her experience in these institutions has greatly contributed to her expertise in cancer research and innovation.

Collaborations

Throughout her career, Jin-Sook Jeong has collaborated with notable colleagues, including In-Hoo Kim and Seong-Wook Lee. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking cancer therapies.

Conclusion

Jin-Sook Jeong's innovative work in cancer research exemplifies her commitment to advancing medical science. Her patents reflect her dedication to improving cancer treatment and diagnosis, making her a significant figure in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…